Answers are grounded in this paper and cite their sources.
In recent years the medication options for the treatment of ADHD in children and young people have increased. The National Institute for Health and Clinical Excellence (NICE) produced updated guidelines in 2006. This paper aims to interpret these guidelines by reviewing the medication options in light of relevant research and clinical practice. The properties of methylphenidate, dexamfetamine and atomoxetine are discussed.
No takes yet. Share an insight, caveat, or question.
Valerie Harpin (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: